SNTI

SNTI

USD

Senti Biosciences Inc. Common Stock

$1.810-0.110 (-5.729%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.920

Haut

$2.020

Bas

$1.800

Volume

0.05M

Fondamentaux de l'Entreprise

Capitalisation Boursière

47.3M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.19M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.26Actuel $1.810Haut $16.94

Actualités Connexes

GlobeNewswire

Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025

Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating relapsed/refractory Acute Myeloid

Voir plus
Senti Bio to Present Updated Clinical Results of First-in-Class Logic Gated CD33/FLT3 Cell Therapy, SENTI-202, at the American Society of Hematology (ASH) Annual Meeting 2025
Analyst Upgrades

HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on Senti Biosciences with a Buy rating and announces Price Target of $12.

Voir plus
HC Wainwright & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $12

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.